The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prevalence of NTRK1/3 fusions in mismatch repair-deficient (dMMR)/microsatellite instable (MSI) tumors of patients with metastatic colorectal cancer (mCRC).
 
Magali Svrcek
Consulting or Advisory Role - Astellas Oncology; Bristol-Myers Squibb; MSD Oncology
 
Raphael Colle
No Relationships to Disclose
 
Anne Cayre
No Relationships to Disclose
 
Pierre Bourgoin
No Relationships to Disclose
 
Romain Cohen
Honoraria - MSD Oncology; SERVIER
Research Funding - SERVIER
 
Thierry Andre
Honoraria - AMGEN; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Pierre Fabre; Roche/Genentech; Sanofi; SERVIER; Ventana Medical Systems
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Clovis Oncology; GamaMabs Pharma; Gastrointestinal Cancers Advice; HalioDX; MSD Oncology; Pierre Fabre; SERVIER; Tesaro
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology; MSD Oncology; MSD Oncology; Roche; Roche/Genentech; Ventana Medical Systems
 
Frederique Madeleine Penault-Llorca
Consulting or Advisory Role - Archer; Bayer; Illumina; NanoString Technologies; Roche
Research Funding - Archer; Bayer; Illumina; Roche
Travel, Accommodations, Expenses - Bayer; Roche
 
Nina Radosevic-Robin
No Relationships to Disclose